Last reviewed · How we verify

NCT04393857

The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors

Completed Last updated 9 February 2021
What this trial tests

trial in Bacterial Vaginoses in 26 participants. Completed in 1 July 2020.

Timeline
15 May 2020
Primary endpoint
1 July 2020
1 July 2020

Quick facts

Lead sponsorPeter Humaidan
StatusCompleted
Study typeOBSERVATIONAL
Enrollment26
Start date15 May 2020
Primary completion1 July 2020
Estimated completion1 July 2020
Sites1 location across Spain

Conditions studied

Sponsor

Peter Humaidan — full company profile →

Who can join

Adults 18 to 35, female only, with Bacterial Vaginoses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to examine the endometrium with state of the art sequencing techniques to investigate the endometrial microbiota. The endometrial microbiota has been perceived to be sterile, however, this seems incorrect from recent studies. Thus, the primary outcome is to compare the rate of ascending infection from the vagina to the endometrium and to investigate which bacteria are capable of inhabiting these environments in healthy oocyte donors. These results will be compared to equivalent samples of IVF patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bacterial Vaginoses

Currently open trials in the same condition.

Other Peter Humaidan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04393857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing